Redefining the Recombinant Technology
rBIO, Co. is a pioneering Synthetic Biology enterprise that excels in the field of genetic engineering. Leveraging our cutting-edge biotech platform, we have successfully devised breakthrough protocols and innovative strategies aimed at optimizing protein synthesis while significantly enhancing peptide yields during the manufacturing process. Our grand vision is to revolutionize industrial-scale peptide and protein production (bio-manufacturing) and pave the way for affordable biosimilars in the market.
Platform
Development
Innovations
In Biosimilars
Latest News & Blogs
Houston startup completes testing, prepares biosimilar insulin drug for clinical trials
Houston biotech startup is one step closer
rBIO Completes Analytical Characterizations of R-biolin, Readies Biosimilar Insulin Drug for Clinical Trial
rBIO's lead biologic drug, R-biolin, aims to
California-founded biotech startup relocates to join Houston’s emerging bioeconomy
San Diego-based rBIO moved to Houston to